DIAN Part 3: Genetic and Data Protection for Volunteers
DIAN asks a lot of its study volunteers...
120 RESULTS
Sort By:
DIAN asks a lot of its study volunteers...
DIAN leaders wrestled with the sensitive issue of genetic confidentiality when reporting data in scientific publications...
Families participating in the DIAN made an impassioned case for pressing on with clinical trials at two recent gatherings of the network...
The Alzheimer’s Prevention Initiative is a proposal to get serious about Alzheimer disease prevention research...
An enormous extended family living in a rural community in Colombia could provide new insights into environmental and genetic factors contributing to Alzheimer’s disease. All family members who were diagnosed...
All presenilin mutations are not created equal. While over 130 mutations in the presenilin-1 (PS1) gene cause...
Last Wednesday, the Japanese film <em>Memories of Tomorrow</em> premiered in Los Angeles, California...
People affected by early-onset familial forms (eFAD) often wonder how discoveries apply to them...
Interest in families stricken with autosomal-dominant Alzheimer disease has intensified in the past few years...
DIAN was founded with the hope that its participating families could be offered a prevention trial and/or treatment trial before too long...
Two papers published this month claim to identify those at greatest risk for Alzheimer’s disease and illuminate the mechanisms behind it...
The first longitudinal data from DIAN conflict with some cross-sectional findings, revealing a small drop in CSF injury markers after the first appearance of symptoms of disease.
By paring back calcium signaling, researchers prevented signs of Alzheimer’s in mice carrying a presenilin mutation. Could the strategy work in humans?
Several thousand people have used preimplantation genetic diagnosis to avoid passing on pathogenic mutations to their babies, but many families with a history of Alzheimer’s or related diseases remain unaware of this option.
Families considering PGD to avoid passing on disease genes face obstacles such as high cost and invasive procedures.